-+ 0.00%
-+ 0.00%
-+ 0.00%

Wedbush Maintains Neutral on Vera Therapeutics, Raises Price Target to $33

Benzinga·12/11/2025 14:27:15
語音播報
Wedbush analyst Laura Chico maintains Vera Therapeutics (NASDAQ:VERA) with a Neutral and raises the price target from $23 to $33.